AAAAAA
Results:
1-13
|
Results: 13
Authors:
San, L
Citation: L. San, Reviewing current practice in drug-substitution treatment in the European Union, ADDICTION, 96(9), 2001, pp. 1367-1368
Authors:
Wright, P
Birkett, M
David, SR
Meehan, K
Ferchland, I
Alaka, KJ
Saunders, JC
Krueger, J
Bradley, P
San, L
Bernardo, M
Reinstein, M
Breier, A
Citation: P. Wright et al., Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia, AM J PSYCHI, 158(7), 2001, pp. 1149-1151
Authors:
San, L
Citation: L. San, New treatments for chemical addictions, ADDICTION, 95(3), 2000, pp. 453-453
Authors:
Rosel, P
Arranz, B
San, L
Vallejo, J
Crespo, JM
Urretavizcaya, M
Navarro, MA
Citation: P. Rosel et al., Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicidevictims, PSYCH RES-N, 99(3), 2000, pp. 173-181
Authors:
Cami, J
Farre, M
Mas, M
Roset, PN
Poudevida, S
Mas, A
San, L
de la Torre, R
Citation: J. Cami et al., Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): Psychomotor performance and subjective effects, J CL PSYCH, 20(4), 2000, pp. 455-466
Authors:
Segura, D
Stramesi, C
Redon, A
Ventura, M
Sanchez, CJ
Gonzalez, G
San, L
Montagna, M
Citation: D. Segura et al., Immunological screening of drugs of abuse and gas chromatographic mass spectrometric confirmation of opiates and cocaine in hair, J CHROMAT B, 724(1), 1999, pp. 9-21
Authors:
San, L
Citation: L. San, Drug misuse prevention, where and why? Comment, ADDICTION, 94(9), 1999, pp. 1307-1309
Authors:
San, L
Arranz, B
Citation: L. San et B. Arranz, Pros and cons of ultrarapid opiate detoxification, ADDICTION, 94(8), 1999, pp. 1240-1241
Authors:
San, L
Citation: L. San, Future research directions and the impact of the MATCH project on researchtechnology in the addictions, ADDICTION, 94(1), 1999, pp. 55-57
Authors:
Rosel, P
Arranz, B
San, L
Urretavizcaya, M
Marcusson, J
Navarro, MA
Citation: P. Rosel et al., 5-HT2A receptors and their second messenger IP3 are only correlated in human brain and not in platelets., NEUROSC R C, 25(3), 1999, pp. 129-138
Authors:
Rosel, P
Arranz, B
Oros, M
Vallejo, J
San, L
Marcusson, J
Navarro, MA
Citation: P. Rosel et al., Different regional distribution of the 5-HT reuptake complex, the 5-HT2A receptors and their second messenger IP3 in human brain., NEUROSC R C, 24(2), 1999, pp. 107-115
Authors:
Arranz, B
Rosel, P
Sarro, S
Zaldivar, E
Cano, R
Navarro, MA
San, L
Citation: B. Arranz et al., Platelet serotonergic binding sites in alcohol-dependent patients, ALC ALCOHOL, 34(5), 1999, pp. 726-732
Authors:
Torrens, M
Domingo-Salvany, A
Alonso, J
Castillo, C
San, L
Citation: M. Torrens et al., Methadone and quality of life, LANCET, 353(9158), 1999, pp. 1101-1101
Risultati:
1-13
|